• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Zoledronic acid may increase bone density in frail elderly women

byShayna BejaimalandJames Jiang
April 14, 2015
in Chronic Disease, Endocrinology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. A single dose of zoledronic acid improved bone mineral density over 2 years in frail elderly women.

2. Rates of fracture or mortality did not differ significantly between zoledronic acid treatment and placebo groups.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Although as many as 85% of frail elderly adults living in long-term homes have osteoporosis, the current use of bisphosphonate therapy is low. Previous randomized controlled trials studying osteoporosis have not examined the efficacy of bisphosphonates in this population, and given physiological differences in the elderly, the efficacy and safety of bisphosphonates may be vastly different. This study aimed to determine the efficacy and safety of zoledronic acid to treat osteoporosis in frail elderly women living in long-term care facilities.

In this randomized controlled trial, a single dose of zoledronic acid improved bone mineral density in the population over 2 years. However, there was no significant decrease in rates of fracture or mortality across groups. Strengths of this study include studying this outcome in a novel yet important patient population. Limitations include the specific patient population selected, which may limit the generalizability of the results. Moreover, this study was not sufficiently powered to determine zoledronic acid’s effect on fracture rates, so further study regarding this question is warranted.

Click to read the study in JAMA Internal Medicine

RELATED REPORTS

Inflammatory bowel disease may be associated with increased risk of osteoporosis and osteopeia

#VisualAbstract: Infrequent Zoledronate over 10 years Prevents Frcatures in Early Postmenopausal Women

Denosumab may increase risk of major adverse cardiovascular events but reduce fracture risk in patients receiving dialysis

Relevant Reading: Once-yearly Zoledronic acid for treatment of postmenopausal osteoporosis

In-Depth [randomized controlled trial]: This double-blind, randomized controlled trial was performed in Pittsburgh, Pennsylvania from December 2007 to March 2012, and randomized a total of 181 frail elderly women to either a single dose of zoledronic acid 5 mg with vitamin D and calcium, or placebo (i.e., vitamin D and calcium alone). The primary outcome was hip and spine bone mineral density at 12 and 24 months. Secondary outcomes included rate of fracture and mortality. Data was analyzed using linear mixed model regression, χ2 and Fisher exact tests.

After randomization, the treatment group included more women with frailty, falls history, diabetes and anticonvulsant use. Women in the treatment group had a greater mean (standard error, SE) bone mineral density changes in the hip and spine at 24 months as compared to the placebo group: 2.6% (0.6%) vs. -1.5% (0.7%); p < 0.001 and 4.5% (0.8%) vs. 0.7% (0.5%); p < 0.001. Similar differences were also seen at the 12-month mark. Differences in fracture rates were not significant between groups – 20% for the treatment group and 16% for the placebo group (OR 1.30; 95%CI 0.61-2.78). Mortality rates also did not differ significantly across groups (OR 1.24; 95% CI 0.54-2.86).

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: bisphosphonatesosteoporosis
Previous Post

Study participants prefer less demanding consent

Next Post

Cutaneous microneedle flu vaccination reduces skin irritation and improves effectiveness [PreClinical]

RelatedReports

Elective colectomy associated with improved survival in ulcerative colitis
Chronic Disease

Inflammatory bowel disease may be associated with increased risk of osteoporosis and osteopeia

April 17, 2025
#VisualAbstract: Infrequent Zoledronate over 10 years Prevents Frcatures in Early Postmenopausal Women
StudyGraphics

#VisualAbstract: Infrequent Zoledronate over 10 years Prevents Frcatures in Early Postmenopausal Women

January 22, 2025
Combined immunotherapy may improve survival in metastatic pancreatic cancer
Chronic Disease

Denosumab may increase risk of major adverse cardiovascular events but reduce fracture risk in patients receiving dialysis

January 13, 2025
Combined immunotherapy may improve survival in metastatic pancreatic cancer
Nephrology

Denosumab increases risk of severe hypocalcemia in women with osteoporosis and chronic kidney disease

November 18, 2024
Next Post
Vaccines for predicted influenza strains may provide wide protection [PreClinical]

Cutaneous microneedle flu vaccination reduces skin irritation and improves effectiveness [PreClinical]

Nonleg venous thromboses associated with PE, longer ICU stay

Patient screening and monitoring improve dabigatran (Pradaxa) adherence

Weight loss surgery may reduce risk of developing type 2 diabetes

Gestational diabetes linked to autism spectrum disorder

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Novartis and Sanofi Urge EU to Raise Drug Prices
  • Physical therapy vs. glucocorticoid injection in patients with meniscal tears and knee osteoarthritis
  • Eli Lilly Takes Legal Action Against Telehealth Startups
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.